Literature DB >> 16728531

Histone deacetylase 1-mediated histone modification regulates osteoblast differentiation.

Hyun Woo Lee1, Jung Hee Suh, A Young Kim, Yun Sok Lee, So Yun Park, Jae Bum Kim.   

Abstract

Osteogenesis is a complex process associated with dramatic changes in gene expression. To elucidate whether modifications in chromatin structure are involved in osteoblast differentiation, we examined the expression levels of histone deacetylases (HDACs) and the degree of histone acetylation at the promoter regions of osteogenic genes. During osteogenesis, total HDAC enzymatic activity was decreased with significant reduction in HDAC1 expression. Consistently, recruitment of HDAC1 to the promoters of osteoblast marker genes, including osterix and osteocalcin, was down-regulated, whereas histone H3 and H4 were hyperacetylated at those promoters during osteoblast differentiation. Moreover, suppression of HDAC activity with a HDAC inhibitor, sodium butyrate, accelerated osteogenesis by inducing osteoblast marker genes including osteopontin and alkaline phosphatase. Consistently, knockdown of HDAC1 by the short interference RNA system stimulated osteoblast differentiation. Taken together, these data propose that down-regulation of HDAC1 is an important process for osteogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16728531     DOI: 10.1210/me.2006-0061

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  85 in total

1.  Histone deacetylase inhibition prevents the growth of primary and metastatic osteosarcoma.

Authors:  Jeremy J McGuire; Niveditha Nerlakanti; Chen Hao Lo; Marilena Tauro; Thomas J Utset-Ward; Damon R Reed; Conor C Lynch
Journal:  Int J Cancer       Date:  2020-06-29       Impact factor: 7.396

Review 2.  Hdac-mediated control of endochondral and intramembranous ossification.

Authors:  Elizabeth W Bradley; Meghan E McGee-Lawrence; Jennifer J Westendorf
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2011       Impact factor: 1.807

3.  Histone deacetylases 2 and 9 are coexpressed and nuclear localized in human molar odontoblasts in vivo.

Authors:  Franz J Klinz; Yüksel Korkmaz; Wilhelm Bloch; Wolfgang H M Raab; Klaus Addicks
Journal:  Histochem Cell Biol       Date:  2012-02-02       Impact factor: 4.304

Review 4.  Histone Deacetylases in Bone Development and Skeletal Disorders.

Authors:  Elizabeth W Bradley; Lomeli R Carpio; Andre J van Wijnen; Meghan E McGee-Lawrence; Jennifer J Westendorf
Journal:  Physiol Rev       Date:  2015-10       Impact factor: 37.312

Review 5.  Histone deacetylases in skeletal development and bone mass maintenance.

Authors:  Meghan E McGee-Lawrence; Jennifer J Westendorf
Journal:  Gene       Date:  2010-12-22       Impact factor: 3.688

Review 6.  Chromatin modifiers and histone modifications in bone formation, regeneration, and therapeutic intervention for bone-related disease.

Authors:  Jonathan A R Gordon; Janet L Stein; Jennifer J Westendorf; Andre J van Wijnen
Journal:  Bone       Date:  2015-03-31       Impact factor: 4.398

7.  Histone deacetylase inhibitors modify pancreatic cell fate determination and amplify endocrine progenitors.

Authors:  Cécile Haumaitre; Olivia Lenoir; Raphaël Scharfmann
Journal:  Mol Cell Biol       Date:  2008-08-18       Impact factor: 4.272

8.  Histone deacetylase 7 associates with Runx2 and represses its activity during osteoblast maturation in a deacetylation-independent manner.

Authors:  Eric D Jensen; Tania M Schroeder; Jaclyn Bailey; Rajaram Gopalakrishnan; Jennifer J Westendorf
Journal:  J Bone Miner Res       Date:  2008-03       Impact factor: 6.741

Review 9.  Recent advances in bone regeneration using adult stem cells.

Authors:  Hadar Zigdon-Giladi; Utai Rudich; Gal Michaeli Geller; Ayelet Evron
Journal:  World J Stem Cells       Date:  2015-04-26       Impact factor: 5.326

Review 10.  Regulation of gene expression in osteoblasts.

Authors:  Eric D Jensen; Rajaram Gopalakrishnan; Jennifer J Westendorf
Journal:  Biofactors       Date:  2010 Jan-Feb       Impact factor: 6.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.